1979
DOI: 10.1007/bf01852108
|View full text |Cite
|
Sign up to set email alerts
|

Effects of some naturally occurring prostaglandins of the D-, E-, and I-type and synthetic analogues on adenylate cyclase of human fat cell ghosts

Abstract: The effects of various prostaglandins originating from arachidonic acid (prostaglandin E2, D2, I2) as well as of methylated analogues of prostaglandin E2 (16,16-dimethyl prostaglandin E2 and 15-S-methyl prostaglandin E2) on the human fat cell adenylate cyclase were studied. In addition, the stable breakdown product of prostaglandin I2, prostaglandin 6-keto-F1-alpha, was tested for activity. Prostaglandin E2 and its methylated analogues as well as prostaglandin D2 and I2 were active stimulators of the human fat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1981
1981
1996
1996

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Since PGI2 is a potent stimulator of adenylate cyclase in a variety of cell types (10)(11)(12) we felt it was important to assess the influence of PGI2 on endothelial cell adenylate cyclase as well. PGI2 proved to be a potent stimulator of endothelial cell cyclic AMP accumulation when the cyclic AMP phosphodiesterase was inhibited.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since PGI2 is a potent stimulator of adenylate cyclase in a variety of cell types (10)(11)(12) we felt it was important to assess the influence of PGI2 on endothelial cell adenylate cyclase as well. PGI2 proved to be a potent stimulator of endothelial cell cyclic AMP accumulation when the cyclic AMP phosphodiesterase was inhibited.…”
Section: Discussionmentioning
confidence: 99%
“…Vascuilar tissue and especially vascular endothelium are rich sources of PGI2 synthetase activity (5-7), and the relationship(s) between the synthesis of the antiaggregatory PGI2 by vascular elements and the synthesis of the proaggregatory molecule thromboxane A2 by platelets have been widely discussed (3,4,8,9). PGI2 is a potent stimulator of platelet adenylate cyclase (3,4), and elevates cyclic AMP levels in ctiltured human foreskin fibroblasts (10), human fat cell ghosts (11), and several clonal cell lines of central nervous system origin (12). PGI2 also elevates cyclic AMP levels in arterial rings (13), but no experiments on the effect of PGI2 on cyclic AMP levels in endothelial cells have been reported to date.…”
Section: Introductionmentioning
confidence: 99%
“…These include cultured human fibroblasts (Gorman, Hamilton & Hopkins, 1979), human fat cell ghosts (Kather & Simon, 1979), guinea-pig lung homogenates (Macdermot & Barnes, 1980) and polymorphonuclear leukocytes (Boxer, Allen, Schmidt, Yoder & Baehner, 1980). Thus, there is the possibility that in these cells an interaction with the thromboxane system could lead to a similar regulation of cell behaviour to that observed in platelets, suggesting that the PGI2/TXA2 system has a wider biological significance.…”
Section: Mechanism Of Actionmentioning
confidence: 99%
“…Prostacyclin increases cyclic AMP levels in cells other than platelets. These include cultured human fibroblasts (Gorman, Hamilton & Hopkins, 1979), human fat cell ghosts (Kather & Simon, 1979), guinea-pig lung homogenates (Macdermot & Barnes, 1980) and polymorphonuclear leukocytes (Boxer, Allen, Schmidt, Yoder & Baehner, 1980). Thus, there is the possibility that in these cells an interaction with the thromboxane system could lead to a similar regulation of cell behaviour to that observed in platelets, suggesting that the PGI2/TXA2 system has a wider biological significance.…”
Section: Mechanism Of Actionmentioning
confidence: 99%